Stay updated on SB3 vs. Herceptin® in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the SB3 vs. Herceptin® in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SB3 vs. Herceptin® in HER2+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Minor site revision updated from v3.4.1 to v3.4.2; no changes to study details or visible content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-16T16:13:52.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1; removed the funding-status notice and Revision: v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-09T12:26:56.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The page now shows a glossary toggle and updates metadata to 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while removing the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-26T09:52:03.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now shown in the page header, replacing Revision: v3.3.3. This change appears to update site revision metadata with no alteration to trial details or user-facing content.
    Difference
    0.1%
    Check dated 2026-01-19T07:32:06.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 to the site footer. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.
    Difference
    0.1%
    Check dated 2025-12-21T21:44:09.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Added a clarification that publications listed are automatically filled from PubMed and may not be about the study, and noted the revision to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-30T06:05:55.000Z thumbnail image

Stay in the know with updates to SB3 vs. Herceptin® in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SB3 vs. Herceptin® in HER2+ Breast Cancer Clinical Trial page.